id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-S-0039-0005,FDA,FDA-1995-S-0039,CFSAN/ONLDS Response to Patton Boggs LLP [Stragen Pharma SA] - Letter,Other,SUP-Supplement,2006-07-07T04:00:00Z,2006,7,,,2016-09-30T14:19:35Z,,0,0,090000648055f44e
FDA-1995-S-0039-0004,FDA,FDA-1995-S-0039,CFSAN/ONLDS to the Division of Dockets Management [Stragen Pharma SA] - Supplement,Other,SUP-Supplement,2006-07-07T04:00:00Z,2006,7,,,2016-09-30T14:19:35Z,,0,0,090000648055f44c